Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
NCT02149264Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jul 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Testosterone TEPI patch in Hypogonadism, sponsored by Ferring Pharmaceuticals. Started Jul 2014; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT02149264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02149264.